Posted on: Friday, November 1, 2019 New Smallpox Vaccine Tested by USAMRIID Receives FDA Approval Homeland Security News Wire
Army scientists played a key role in testing a new smallpox vaccine approved last week by the U.S. Food and Drug Administration. Marketed under the brand name JYNNEOS, the product, developed by Bavarian Nordic, is a live, non-replicating vaccine for the prevention of both smallpox and monkeypox disease in adults.
The St. Louis Fusion Center: Terrorism Early Warning Group is an information sharing initiative owned and operated by the St. Louis Fusion Center. Should you have any questions please email firstname.lastname@example.org.